JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SELLINGER, O. Z.
Right arrow Articles by MOHRMAN, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SELLINGER, O. Z.
Right arrow Articles by MOHRMAN, M. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 167, Issue 1, 63-76, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


INTRACELLULAR DISTRIBUTION OF C14-HEMICHOLINIUM-3 IN THE CANINE CAUDATE NUCLEUS AND HIPPOCAMPUS

OTTO Z. SELLINGER 1, EDWARD F. DOMINO 1, VERNON B. HAARSTAD 1, and MARGARET E. MOHRMAN 1

1 Neuropsychopharmacology Research Program, Departments of Pharmacology and Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan; Tulane University, New Orleans, Louisiana

C14-hemicholinium-3, methyl-labeled (C14-HC-3), was administered intraventricularly to acute dogs. At 30, 60 and 240 min postinjection, its intracellular distribution was determined in the caudate nucleus and hippocampus. Simultaneously the intracellular localization of succinate reductase, glutamine transferase, acetylcholinesterase (AChE) and aryl sulfatase was established and the validity of their use as subcellular markers for caudate and hippocampus was confirmed. Although C14-HC-3 accumulated in the heavy particulate fraction NEML (containing nerve endings, mitochondria and lysosomes) in both brain regions, the rate of its concentration was considerably higher in the caudate. Discontinuous density gradient centrifugation of fraction NEML yielded subfractions A, B, C, D and E. Although AChE showed enrichment in fractions B and C, up to 30% appeared in fraction D, which also exhibited (in the caudate) the highest relative specific concentration of C14-HC-3. Centrifugation of caudate fractions C and D in continuous density gradients confirmed the association of AChE and of C14-HC-3 with, and the real density difference between, the two granule populations comprising the fractions C and D. Experiments designed to assess the extent of the association of C14-HC-3 with nerveending membranes revealed that approximately 11% of the total NEML-associated C14-HC-3 resists attempts at extrusion and/or solubilization and, hence, denotes tightly bound C14-HC-3. The findings are interpreted to indicate that the majority of fraction C nerve endings contain few mitochondria, have a low affinity for HC-3 and exhibit high levels of AChE, while those of fraction D have most of the mitochondria-filled nerve endings, 30% of the AChE and a high affinity for HC-3. It is suggested that there are two populations of cholinergic nerve endings in the caudate nucleus.

Submitted on May 31, 1968
Accepted on January 10, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.